Sialylation regulates brain structure and function

FASEB Journal

Volumn 29, Issue 7, 2015, Pages 3040-3053

  Yoo, Seung Wan ^a   Motari, Mary G ^a   Susuki, Keiichiro ^d   Prendergast, Jillian ^a   Mountney, Andrea ^b   Hurtado, Andres ^a,c   Schnaar, Ronald L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Animal models; Behavior; Gangliosides; Myelin; Oligodendrocyte precursor cells

Indexed keywords

GANGLIOSIDE; GLYCOPROTEIN; MYELIN; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; MUTANT PROTEIN; NERVE PROTEIN; SIALIC ACID DERIVATIVE; SIALOGLYCOPROTEIN; SIALYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN SIZE; CONTROLLED STUDY; GENE MUTATION; HIPPOCAMPUS; HISTOLOGY; MOUSE; MYELIN DEFICIENCY; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; RANVIER NODE; REGULATORY MECHANISM; SIALYLATION; ANATOMY AND HISTOLOGY; ANIMAL; ANIMAL BEHAVIOR; ASTROCYTE; BRAIN; C57BL MOUSE; DEFICIENCY; DEMYELINATING DISEASE; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MICROGLIA; MUTANT MOUSE STRAIN; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MUS; VERTEBRATA;

ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN; DEMYELINATING DISEASES; GANGLIOSIDES; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICROGLIA; MODELS, ANIMAL; MUTANT PROTEINS; NERVE TISSUE PROTEINS; NEURONS; SIALIC ACIDS; SIALOGLYCOPROTEINS; SIALYLTRANSFERASES;

EID: 84940404090     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-270983     Document Type: Article

References (58)

1. Schnaar, R. L., Gerardy-Schahn, R., and Hildebrandt, H. (2014) Sialic acids in the brain: gangliosides and polysialic acid in nervous systemdevelopment, stability, disease, and regeneration. Physiol. Rev. 94, 461-518.
2. Cummings, R. D., and Pierce, J. M. (2014) The challenge and promise of glycomics. Chem. Biol. 21, 1-15.
3. Hart, G.W., and Copeland, R. J. (2010) Glycomics hits the big time. Cell 143, 672-676.
4. Cohen, M., and Varki, A. (2010) The sialome-far more than the sum of its parts. OMICS 14, 455-464.
5. Tettamanti, G., Bonali, F., Marchesini, S., and Zambotti, V. (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta 296, 160-170.
6. Svennerholm, L. (1994) Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog. Brain Res. 101, XI-XIV.
7. Sturgill, E. R., Aoki, K., Lopez, P. H., Colacurcio, D., Vajn, K., Lorenzini, I., Majić, S., Yang, W.H., Heffer, M., Tiemeyer, M., Marth, J. D., and Schnaar, R. L. (2012) Biosynthesis of the major brain gangliosides GD1a and GT1b. Glycobiology 22, 1289-1301.
8. Audry, M., Jeanneau, C., Imberty, A., Harduin-Lepers, A., Delannoy, P., and Breton, C. (2011) Current trends in the structure-activity relationships of sialyltransferases. Glycobiology 21, 716-726.
9. Kolter, T., Proia, R. L., and Sandhoff, K. (2002) Combinatorial ganglioside biosynthesis. J. Biol. Chem. 277, 25859-25862.
10. Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., and Crosby, A. H. (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat. Genet. 36, 1225-1229.
11. Fragaki, K., Ait-El-Mkadem, S., Chaussenot, A., Gire, C., Mengual, R., Bonesso, L., Bénéteau, M., Ricci, J. E., Desquiret-Dumas, V., Procaccio, V., Rötig, A., and Paquis-Flucklinger, V. (2013) Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur. J. Hum. Genet. 21, 528-534.
12. Boccuto, L., Aoki, K., Flanagan-Steet, H., Chen, C. F., Fan, X., Bartel, F., Petukh, M., Pittman, A., Saul, R., Chaubey, A., Alexov, E., Tiemeyer, M., Steet, R., and Schwartz, C. E. (2014) A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum. Mol. Genet. 23, 418-433.
13. Boukhris, A., Schule, R., Loureiro, J. L., Lourenço, C. M., Mundwiller, E., Gonzalez, M. A., Charles, P., Gauthier, J., Rekik, I., Acosta Lebrigio, R. F., Gaussen, M., Speziani, F., Ferbert, A., Feki, I., Caballero-Oteyza, A., Dionne-Laporte, A., Amri, M., Noreau, A., Forlani, S., Cruz, V. T., Mochel, F., Coutinho, P., Dion, P., Mhiri, C., Schols, L., Pouget, J., Darios, F., Rouleau, G. A., Marques, Jr. W., Brice, A., Durr, A., Zuchner, S., and Stevanin, G. (2013) Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am. J. Hum. Genet. 93, 118-123.
14. Harlalka, G.V., Lehman, A., Chioza, B., Baple, E. L., Maroofian, R., Cross, H., Sreekantan-Nair, A., Priestman, D. A., Al-Turki, S., McEntagart, M. E., Proukakis, C., Royle, L., Kozak, R. P., Bastaki, L., Patton, M., Wagner, K., Coblentz, R., Price, J., Mezei, M., Schlade-Bartusiak, K., Platt, F. M., Hurles, M. E., and Crosby, A. H. (2013) Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain 136, 3618-3624.
15. Hu, H., Eggers, K., Chen, W., Garshasbi, M., Motazacker, M. M., Wrogemann, K., Kahrizi, K., Tzschach, A., Hosseini, M., Bahman, I., Hucho, T., Mühlenhoff, M., Gerardy-Schahn, R., Najmabadi, H., Ropers, H. H., and Kuss, A. W. (2011) ST3GAL3 mutations impair the development of higher cognitive functions. Am. J.Hum.Genet. 89, 407-414.
16. Edvardson, S., Baumann, A.M., Mühlenhoff, M., Stephan, O., Kuss, A.W., Shaag, A., He, L., Zenvirt, S., Tanzi, R., Gerardy-Schahn, R., and Elpeleg, O. (2013) West syndrome caused by ST3Gal-III deficiency. Epilepsia 54, e24-e27.
17. Ellies, L. G., Sperandio, M., Underhill, G. H., Yousif, J., Smith, M., Priatel, J. J., Kansas, G. S., Ley, K., and Marth, J. D. (2002) Sialyltransferase specificity in selectin ligand formation. Blood 100, 3618-3625.
18. Susuki, K., Chang, K. J., Zollinger, D. R., Liu, Y., Ogawa, Y., Eshed-Eisenbach, Y., Dours-Zimmermann, M. T., Oses-Prieto, J. A., Burlingame, A. L., Seidenbecher, C. I., Zimmermann, D. R., Oohashi, T., Peles, E., and Rasband, M. N. (2013) Three mechanisms assemble central nervous system nodes of Ranvier. Neuron 78, 469-482.
19. Schafer, D. P., Bansal, R., Hedstrom, K. L., Pfeiffer, S. E., and Rasband, M. N. (2004) Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J.Neurosci. 24, 3176-3185.
20. Barres, B.A., Raff, M.C., Gaese, F., Bartke, I., Dechant, G., and Barde, Y. A. (1994) A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367, 371-375.
21. Abe, A., Radin, N. S., Shayman, J. A., Wotring, L. L., Zipkin, R. E., Sivakumar, R., Ruggieri, J. M., Carson, K. G., and Ganem, B. (1995) Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J. Lipid Res. 36, 611-621.
22. Hamers, F. P., Lankhorst, A. J., van Laar, T. J., Veldhuis, W. B., and Gispen, W. H. (2001) Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J. Neurotrauma 18, 187-201.
23. Mountney, A., Leung, L. Y., Pedersen, R., Shear, D., and Tortella, F. (2013) Longitudinal assessment of gait abnormalities following penetrating ballistic-like brain injury in rats. J.Neurosci.Methods 212, 1-16.
24. Sun, J., Shaper, N. L., Itonori, S., Heffer-Lauc, M., Sheikh, K. A., and Schnaar, R. L. (2004) Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides. Glycobiology 14, 851-857.
25. Nairn, A. V., Dela Rosa, M., and Moremen, K. W. (2010) Transcript analysis of stem cells. Methods Enzymol. 479, 73-91.
26. Li, C., Tropak, M. B., Gerlai, R., Clapoff, S., Abramow-Newerly, W., Trapp, B., Peterson, A., and Roder, J. (1994) Myelination in the absence of myelin-associated glycoprotein. Nature 369, 747-750.
27. Liu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., Padovani-Claudio, D., He, T., Choi, K., Lane, T. E., Miller, R. H., and Ransohoff, R.M. (2010) CXCR2-positiveneutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat. Neurosci. 13, 319-326.
28. Shen, S., Sandoval, J., Swiss, V.A., Li, J., Dupree, J., Franklin, R. J., and Casaccia-Bonnefil, P. (2008) Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci. 11, 1024-1034.
29. McKinnon, R. D., Waldron, S., and Kiel, M. E. (2005) PDGF alpha-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 39-kinase and phospholipase Cgamma pathways during oligodendrocyte maturation. J. Neurosci. 25, 3499-3508.
30. Zhu, Q., Zhao, X., Zheng, K., Li, H., Huang, H., Zhang, Z., Mastracci, T., Wegner, M., Chen, Y., Sussel, L., and Qiu, M. (2014) Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS. Development 141, 548-555.
31. Miljan, E. A., and Bremer, E. G. (2002) Regulation of growth factor receptors by gangliosides. Sci. STKE 2002, re15.
32. Kaucic, K., Liu, Y., and Ladisch, S. (2006) Modulation of growth factor signaling by gangliosides: positive or negative? Methods Enzymol. 417, 168-185.
33. Liu, Y., Li, R., and Ladisch, S. (2004) Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J. Biol. Chem. 279, 36481-36489.
34. Li, R., Manela, J., Kong, Y., and Ladisch, S. (2000) Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J. Biol. Chem. 275, 34213-34223.
35. Mitsuda, T., Furukawa, K., Fukumoto, S., Miyazaki, H., Urano, T., and Furukawa, K. (2002) Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched microdomains and in the suppression of cell growth signals. J. Biol. Chem. 277, 11239-11246.
36. Rodriguiz, R. M., and Wetsel, W. C. (2006) Assessments of cognitive deficits inmutant mice. In Animal Models of Cognitive Impairment (Levin, E. D., and Buccafusco, J. J., eds.), pp. 223-284, CRC Press, Boca Raton, FL.
37. Varki, A. (2011) Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells. Cold Spring Harb. Perspect. Biol. 3, a005462.
38. Wang, H., Bright, A., Xin, B., Bockoven, J.R., and Paller, A. S. (2013) Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency. Am. J. Med. Genet. A. 161A, 875-879.
39. Chiavegatto, S., Sun, J., Nelson, R. J., and Schnaar, R. L. (2000) A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp. Neurol. 166, 227-234.
40. Pan, B., Fromholt, S.E., Hess, E. J., Crawford, T.O., Griffin, J.W., Sheikh, K. A., and Schnaar, R. L. (2005) Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp. Neurol. 195, 208-217.
41. Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., Sandhoff, K., and Proia, R. L. (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J. Biol. Chem. 276, 6885-6888.
42. Matsuhashi, H., Horii, Y., and Kato, K. (2003) Region-specific and epileptogenic-dependent expression of six subtypes of alpha2, 3- sialyltransferase in the adult mouse brain. J. Neurochem. 84, 53-66.
43. Van der Voorn, J. P., Kamphorst, W., van der Knaap, M. S., and Powers, J. M. (2004) The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction. Acta Neuropathol. 107, 539-545.
44. Gard, A. L., and Pfeiffer, S. E. (1990) Two proliferative stages of the oligodendrocyte lineage (A2B5+O4- andO4+GalC-) under different mitogenic control. Neuron 5, 615-625.
45. Farrer, R. G., and Quarles, R. H. (1999) GT3 and its O-acetylated derivative are the principal A2B5-reactive gangliosides in cultured O2A lineage cells and are down-regulated along with O-acetyl GD3 during differentiation to oligodendrocytes. J. Neurosci. Res. 57, 371-380.
46. Yim, S. H., Farrer, R. G., and Quarles, R. H. (1995) Expression of glycolipids and myelin-associated glycoprotein during the differentiation of oligodendrocytes: comparison of the CG-4 glial cell line to primary cultures. Dev. Neurosci. 17, 171-180.
47. Nielsen, J. A., Maric, D., Lau, P., Barker, J. L., and Hudson, L. D. (2006) Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J. Neurosci. 26, 9881-9891.
48. Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Furukawa, K., Rasband, M. N., and Yuki, N. (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55, 746-757.
49. Sheikh, K. A., Sun, J., Liu, Y., Kawai, H., Crawford, T.O., Proia, R. L., Griffin, J. W., and Schnaar, R. L. (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc.Natl. Acad. Sci. USA 96, 7532-7537.
50. Schnaar, R. L. (2010) Brain gangliosides in axon-myelin stability and axon regeneration. FEBS Lett. 584, 1741-1747.
51. Yamashita, T., Wu, Y. P., Sandhoff, R., Werth, N., Mizukami, H., Ellis, J.M., Dupree, J. L., Geyer, R., Sandhoff, K., and Proia, R. L. (2005) Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc. Natl. Acad. Sci. USA 102, 2725-2730.
52. Collins, B.E., Yang, L. J. S., Mukhopadhyay, G., Filbin, M.T., Kiso, M., Hasegawa, A., and Schnaar, R. L. (1997) Sialic acid specificity of myelin-associated glycoprotein binding. J. Biol. Chem. 272, 1248-1255.
53. Yang, L. J. S., Zeller, C. B., Shaper, N. L., Kiso, M., Hasegawa, A., Shapiro, R. E., and Schnaar, R. L. (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA 93, 814-818.
54. Fruttiger, M., Montag, D., Schachner, M., and Martini, R. (1995) Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 7, 511-515.
55. Schnaar, R. L. (2014) ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3). In Handbook of Glycosyltransferases and RelatedGenes, 2nd ed. (Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., and Angata, T., eds.), pp. 657-666, Springer, Tokyo.
56. Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J.L., Werth, N., Sandhoff, R., Sandhoff, K., and Proia, R. L. (2003) Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci. USA 100, 3445-3449.
57. Tajima, O., Egashira, N., Ohmi, Y., Fukue, Y., Mishima, K., Iwasaki, K., Fujiwara, M., Inokuchi, J., Sugiura, Y., Furukawa, K., and Furukawa, K. (2009) Reduced motor and sensory functions and emotional response in GM3-only mice: emergence from early stage of life and exacerbation with aging. Behav. Brain Res. 198, 74-82.
58. Yao, D., McGonigal, R., Barrie, J. A., Cappell, J., Cunningham, M. E., Meehan, G. R., Fewou, S. N., Edgar, J. M., Rowan, E., Ohmi, Y., Furukawa, K., Furukawa, K., Brophy, P. J., and Willison, H. J. (2014) Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice. J. Neurosci. 34, 880-891.